Literature DB >> 300174

Prevention of autoimmunity in experimental lupus erythematosus by soluble immune response suppressor.

R S Krakauer, W Strober, D L Rippeon, T A Waldmann.   

Abstract

Young NZB/W mice, treated with injections of soluble immune response suppressor (SIRS)(supernatant from mouse spleen cells exposed to concanavalin A), showed decreased immunoglobulin levels, less antibody to cell nuclei, less proteinuria, and less renal pathology as compared with NZB/W mice receiving a control preparation. Thus, SIRS administration beginning at an early age appears to be an effective therapy of the autoimmune disease in NZB/W mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300174     DOI: 10.1126/science.300174

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  Influence of dietary restriction on immunologic function and renal disease in (NZB x NZW) F1 mice.

Authors:  G Fernandes; P Friend; E J Yunis; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

Review 3.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

4.  Spontaneous suppressor cell function in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

5.  Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions.

Authors:  J Laurence; A B Gottlieb; H G Kunkel
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 6.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

7.  Production of migration inhibition factor (MIF) by purified human T cell subpopulations.

Authors:  R J Warrington; S L Olivier; P J Sauder; W J Rutherford
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

Review 8.  Regulatory T cells in systemic lupus erythematosus: past, present and future.

Authors:  David A Horwitz
Journal:  Arthritis Res Ther       Date:  2008-11-14       Impact factor: 5.156

Review 9.  Animal models of human systemic lupus erythematosus.

Authors:  D P Huston; A D Steinberg
Journal:  Yale J Biol Med       Date:  1979 May-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.